Categories for Uncategorized

Redwood Pharma carries out a rights issue with the aim of replacing the existing credit facility

August 25, 2019 9:00 pm Published by jonas

On August 25, 2019, the Board of Directors of Redwood Pharma AB (publ) decided to carry out a rights issue... View Article

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.